Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
Internal Medicine · OKLAHOMA CITY, OK · NPI 1972570067
Verified facts
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
We did not find matching Open Payments records for this doctor in the selected program year.
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Eliquis | Apixaban | 435 | 48 |
| Atorvastatin Calcium | Atorvastatin Calcium | 403 | 74 |
| Gabapentin | Gabapentin | 342 | 67 |
| Amlodipine Besylate | Amlodipine Besylate | 326 | 62 |
| Furosemide | Furosemide | 326 | 60 |
| Levothyroxine Sodium | Levothyroxine Sodium | 296 | 55 |
| Potassium Chloride | Potassium Chloride | 260 | 52 |
| Pantoprazole Sodium | Pantoprazole Sodium | 203 | 46 |
| Carvedilol | Carvedilol | 198 | 36 |
| Lisinopril | Lisinopril | 198 | 33 |
| Sertraline Hcl | Sertraline Hcl | 190 | 35 |
| Losartan Potassium | Losartan Potassium | 161 | 25 |
| Omeprazole | Omeprazole | 158 | 36 |
| Metoprolol Succinate | Metoprolol Succinate | 122 | 23 |
| Metoprolol Tartrate | Metoprolol Tartrate | 118 | 23 |
| Mirtazapine | Mirtazapine | 116 | 23 |
| Divalproex Sodium | Divalproex Sodium | 112 | 24 |
| Buspirone Hcl | Buspirone Hcl | 109 | 25 |
| Trazodone Hcl | Trazodone Hcl | 106 | 29 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 104 | 35 |
| Clopidogrel | Clopidogrel Bisulfate | 103 | 23 |
| Allopurinol | Allopurinol | 99 | 18 |
| Escitalopram Oxalate | Escitalopram Oxalate | 98 | 17 |
| Fluticasone Propionate | Fluticasone Propionate | 96 | 26 |
| Duloxetine Hcl | Duloxetine Hcl | 95 | 17 |
| Donepezil Hcl | Donepezil Hcl | 94 | 18 |
| Dropsafe Pen Needle | Pen Needle, Diabetic, Safety | 92 | 26 |
| Tamsulosin Hcl | Tamsulosin Hcl | 91 | 19 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 86 | 16 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 85 | 23 |
| Oxybutynin Chloride | Oxybutynin Chloride | 82 | 14 |
| Loperamide | Loperamide Hcl | 81 | 32 |
| Metformin Hcl | Metformin Hcl | 73 | 16 |
| Hydralazine Hcl | Hydralazine Hcl | 72 | 14 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 72 | 14 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 72 | 21 |
| Famotidine | Famotidine | 70 | 15 |
| Xarelto | Rivaroxaban | 69 | 12 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 66 | 20 |
| Memantine Hcl | Memantine Hcl | 66 | 12 |
| Pravastatin Sodium | Pravastatin Sodium | 61 | 14 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 60 | 31 |
| Ondansetron Hcl | Ondansetron Hcl | 60 | 30 |
| Quetiapine Fumarate | Quetiapine Fumarate | 60 | 14 |
| Spironolactone | Spironolactone | 60 | 14 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 56 | 11 |
| Brilinta | Ticagrelor | 52 | suppressed |
| Lorazepam | Lorazepam | 52 | 23 |
| Ropinirole Hcl | Ropinirole Hcl | 52 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 50 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 49 | suppressed |
| Levetiracetam | Levetiracetam | 48 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 44 | 44 |
| Tramadol Hcl | Tramadol Hcl | 44 | 22 |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 43 | 20 |
| Gemtesa | Vibegron | 42 | suppressed |
| Humalog | Insulin Lispro | 42 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 40 | 13 |
| Insulin Aspart Flexpen | Insulin Aspart | 39 | suppressed |
| Baclofen | Baclofen | 38 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 36 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 35 | 11 |
| Jardiance | Empagliflozin | 35 | suppressed |
| Nifedipine Er | Nifedipine | 34 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 32 | 24 |
| Albuterol Sulfate | Albuterol Sulfate | 31 | 18 |
| Aripiprazole | Aripiprazole | 31 | suppressed |
| Pregabalin | Pregabalin | 31 | suppressed |
| Risperidone | Risperidone | 31 | suppressed |
| Simvastatin | Simvastatin | 31 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 30 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 30 | suppressed |
| Movantik | Naloxegol Oxalate | 30 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 29 | suppressed |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 29 | suppressed |
| Olanzapine | Olanzapine | 28 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 28 | suppressed |
| Levofloxacin | Levofloxacin | 27 | 21 |
| Lovastatin | Lovastatin | 27 | suppressed |
| Cephalexin | Cephalexin | 26 | 21 |
| Torsemide | Torsemide | 26 | suppressed |
| Fluconazole | Fluconazole | 25 | 17 |
| Ezetimibe | Ezetimibe | 24 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 24 | suppressed |
| Myrbetriq | Mirabegron | 24 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 24 | suppressed |
| Atenolol | Atenolol | 23 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 23 | suppressed |
| Finasteride | Finasteride | 23 | suppressed |
| Novolog Flexpen | Insulin Aspart | 23 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 23 | 13 |
| Trihexyphenidyl Hcl | Trihexyphenidyl Hcl | 23 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 23 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 22 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 22 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 22 | 12 |
| Latanoprost | Latanoprost | 22 | suppressed |
| Linzess | Linaclotide | 22 | suppressed |
| Meloxicam | Meloxicam | 22 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 22 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 21 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 21 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 21 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 19 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 19 | suppressed |
| Novofine Autocover | Pen Needle, Diabetic, Safety | 18 | suppressed |
| Primidone | Primidone | 18 | suppressed |
| Trulicity | Dulaglutide | 18 | suppressed |
| Azithromycin | Azithromycin | 17 | 16 |
| Gemfibrozil | Gemfibrozil | 17 | suppressed |
| Glimepiride | Glimepiride | 17 | suppressed |
| Insulin Aspart | Insulin Aspart | 17 | suppressed |
| Lansoprazole | Lansoprazole | 17 | suppressed |
| Bupropion Xl | Bupropion Hcl | 16 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 16 | 16 |
| Nystop | Nystatin | 16 | 11 |
| Ondansetron Odt | Ondansetron | 16 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 16 | suppressed |
| Sucralfate | Sucralfate | 16 | suppressed |
| Admelog | Insulin Lispro | 15 | suppressed |
| Glipizide | Glipizide | 15 | suppressed |
| Hydrocortisone | Hydrocortisone | 15 | suppressed |
| Telmisartan | Telmisartan | 15 | suppressed |
| Acarbose | Acarbose | 14 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 14 | 14 |
| Brimonidine Tartrate-Timolol | Brimonidine Tartrate/Timolol | 14 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 14 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 14 | suppressed |
| Estradiol | Estradiol | 14 | suppressed |
| Levemir | Insulin Detemir | 14 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 14 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 14 | 11 |
| Budesonide | Budesonide | 13 | suppressed |
| Lamotrigine | Lamotrigine | 13 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 13 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 12 | suppressed |
| Fluphenazine Hcl | Fluphenazine Hcl | 12 | suppressed |
| Folic Acid | Folic Acid | 12 | suppressed |
| Glucagon Emergency Kit | Glucagon | 12 | suppressed |
| Haloperidol | Haloperidol | 12 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 12 | suppressed |
| Niacin Er | Niacin | 12 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 12 | suppressed |
| Celecoxib | Celecoxib | 11 | suppressed |
| Chlorthalidone | Chlorthalidone | 11 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 11 | suppressed |
| Glipizide Er | Glipizide | 11 | suppressed |
| Ozempic | Semaglutide | 11 | suppressed |
| Pentoxifylline | Pentoxifylline | 11 | suppressed |
| Topiramate | Topiramate | 11 | suppressed |
| Valsartan | Valsartan | 11 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error